Company: INKT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0000950170-25-072789
Chunk: 0

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 0
---
MINK THERAPEUTICS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(Unaudited) 

     March 31,2025

     December 31,2024

     ASSETS

     Cash and cash equivalents
      
     $
     3,234,899

     $
     4,577,040

     Prepaid expenses

     236,203

     246,600

     Other current assets

     108,711

     164,244

     Total current assets

     3,579,813

     4,987,884

     Equipment, net of accumulated depreciation of $578,544 and $524,639 at  March 31, 2025 and December 31, 2024, respectively

     687,500

     732,929

     Total assets
      
     $
     4,267,313

     $
     5,720,813

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Accounts payable
      
     $
     2,661,195

     $
     2,728,212

     Accrued liabilities

     1,971,023

     1,873,561

     Related party note

     5,117,534

     —

     Other current liabilities

     2,370,315

     2,357,903

     Total current liabilities

     12,120,067

     6,959,676

     Related party note

     —

     4,924,612

     Due to related parties

     13,939,025

     13,422,407

     Commitments and contingencies

     STOCKHOLDERS’ DEFICIT

     Common stock, par value $0.00001 per share; 150,000,000 shares   authorized; 3,965,597 and 3,963,045 shares issued at   March 31, 2025 and December 31, 2024, respectively

     40

     40

     Additional paid-in capital

     125,819,054

     125,227,389

     Accumulated other comprehensive loss

     (662,441
     )

     (631,576
     )

     Accumulated deficit

     (